Topical gene editing therapeutics using lipid nanoparticles: ‘gene creams’ for genetic skin diseases?
Open Access
- 27 December 2023
- journal article
- review article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 190 (5) , 617-627
Abstract
Patients living with inherited skin diseases have benefited from recent advances in DNA sequencing technologies that provide new or improved diagnostics. However, developing and delivering new treatments for the ‘genodermatoses’ remains challenging. The goal of creating topical preparations that can recover the inherent gene pathology remains largely aspirational. However, recent progress in two fields – the chemistry of topical delivery formulations (lipid nanoparticles) and the molecular biology of gene repair (CRISPR-Cas9, base and prime editing) – presents new opportunities to address this unmet need. In this review, we discuss how lipid nanoparticle delivery vehicles could be used to deliver gene-editing tools to formulate topical ‘gene creams’ suitable for the treatment of genodermatoses. We summarize the historical landscape of topical therapeutics and advances in gene editing that may herald an era of new therapies for patients with inherited skin disorders.Keywords
This publication has 96 references indexed in Scilit:
- Epidermolysis Bullosa: A Review of the Tissue-Engineered Skin Substitutes Used to Treat WoundsMolecular Diagnosis & Therapy, 2022
- Anionic Lipid Nanoparticles Preferentially Deliver mRNA to the Hepatic Reticuloendothelial SystemAdvanced Materials, 2022
- Strategies for nonviral nanoparticle‐based delivery of CRISPR/Cas9 therapeuticsWIREs Nanomedicine and Nanobiotechnology, 2019
- Fast and Efficient CRISPR/Cas9 Genome Editing In Vivo Enabled by Bioreducible Lipid and Messenger RNA NanoparticlesAdvanced Materials, 2019
- Flightless I over‐expression impairs skin barrier development, function and recovery following skin blisteringThe Journal of Pathology, 2013
- Transdermal Delivery of Molecules is Limited by Full Epidermis, Not Just Stratum CorneumPharmaceutical Research, 2012
- Flexible Nanosomes (SECosomes) Enable Efficient siRNA Delivery in Cultured Primary Skin Cells and in the Viable Epidermis of Ex Vivo Human SkinAdvanced Functional Materials, 2010
- Lipid nanoparticles for improved topical application of drugs for skin diseases☆Advanced Drug Delivery Reviews, 2007
- Lipid vesicles and other colloids as drug carriers on the skinAdvanced Drug Delivery Reviews, 2004
- Liposomes and niosomes as topical drug carriers: dermal and transdermal drug deliveryJournal of Controlled Release, 1994